Empirically supported treatments for panic disorder: Costs, benefits, and stepped care
Empirically supported treatments for panic disorder: Costs, benefits, and stepped care
复制标题
DOI：
10.1037//0022-006x.68.4.556
复制
发表时间：
2000-08-01
影响因子：
5.9
通讯作者：
Maki, KM
中科院分区：
文献类型：
--
作者：
Otto, MW;Pollack, MH;Maki, KM
治疗结果表明，认知行为疗法（CBT）和药物疗法为惊恐障碍提供了类似的短期治疗收益，CBT可以提供更佳的治疗收益维持，而无需持续治疗。然而，疗效并不是患者唯一的考虑因素，由于有限的医疗资源，这些治疗的成本效益比的评估是重要的，在本文中，作者回顾了这些治疗的相对疗效，可接受性，耐受性和成本的估计;实证研究认知的成本和结果-行为和药理学干预，因为他们是在一个专门从事这些治疗的门诊诊所提供;并评论这些数据如何告知一个阶梯式的治疗模型。对“服务”数据的分析表明，CBT在治疗前严重程度和急性治疗结果方面至少与药物治疗相当，CBT是一种特别具有成本效益的治疗选择。
Treatment outcome findings suggest that cognitive-behavioral therapy (CBT) and pharmacotherapy offer similar short-term treatment gains for panic disorder and that CBT may afford more optimal maintenance of treatment gains without the need for ongoing treatment. However, efficacy is not the only consideration for patients, and because of limited health care resources, evaluation of the cost-benefit ratio of these treatments is important, in this article, the authors review estimates of the relative efficacy, acceptability, tolerability, and costs of these treatments; empirically examine the costs and outcome of cognitive-behavioral and pharmacologic interventions as they are delivered in an outpatient clinic specializing in these treatments; and comment on how these data inform a stepped can model of treatment. Analysis of the "services" data indicated that CBT was at least equal to pharmacatherapy in terms of pretreatment severity and acute treatment outcome and that CBT is an especially cost-effective treatment option.